UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Prenatal care: Patient education, health promotion, and safety of commonly used drugs

Authors
Charles J Lockwood, MD, MHCM
Urania Magriples, MD
Section Editor
Susan M Ramin, MD
Deputy Editor
Vanessa A Barss, MD, FACOG

INTRODUCTION

Prenatal care in the first few prenatal visits involves a substantial amount of patient education and health promotion. This topic will discuss routine patient education and health promotion in early pregnancy and use of common medications across pregnancy. Other important aspects of prenatal care are reviewed separately. (See "Prenatal care: Initial assessment" and "Prenatal care: Second and third trimesters".)

PATIENT EDUCATION AND HEALTH PROMOTION

Practice issues — Women should be informed about the following:

When to call the provider (eg, vaginal bleeding or change in vaginal discharge, leakage of fluid from the vagina, fever, pain, vomiting, acute shortness of breath, calf or leg pain, headache, visual changes, dysuria, pruritus, uterine contractions, crampy abdominal pain, decreased fetal activity [after perception of fetal activity has become established], fainting or dizziness, or personal concern about a change in health status).

How to reach the provider after business hours, coverage arrangements, and the role of various office personnel.

The hospital where delivery will occur.

                                                    

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: May 2017. | This topic last updated: Jun 21, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Vitamin supplementation in pregnancy. Drug Ther Bull 2016; 54:81.
  2. www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm (Accessed on May 07, 2017).
  3. Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; :CD009997.
  4. www.nap.edu/read/10026/chapter/11#291 (Accessed on May 07, 2017).
  5. Klinich KD, Flannagan CA, Rupp JD, et al. Fetal outcome in motor-vehicle crashes: effects of crash characteristics and maternal restraint. Am J Obstet Gynecol 2008; 198:450.e1.
  6. Motozawa Y, Hitosugi M, Abe T, Tokudome S. Effects of seat belts worn by pregnant drivers during low-impact collisions. Am J Obstet Gynecol 2010; 203:62.e1.
  7. Schiff MA, Mack CD, Kaufman RP, et al. The effect of air bags on pregnancy outcomes in Washington State: 2002-2005. Obstet Gynecol 2010; 115:85.
  8. American College of Obstetricians and Gynecologists. Car safety for you and your baby. www.acog.org/publications/patient_education/bp018.cfm (Accessed on December 10, 2010).
  9. Grobman WA, Gilbert SA, Iams JD, et al. Activity restriction among women with a short cervix. Obstet Gynecol 2013; 121:1181.
  10. McCall CA, Grimes DA, Lyerly AD. "Therapeutic" bed rest in pregnancy: unethical and unsupported by data. Obstet Gynecol 2013; 121:1305.
  11. Maloni JA. Lack of evidence for prescription of antepartum bed rest. Expert Rev Obstet Gynecol 2011; 6:385.
  12. Biggio JR Jr. Bed rest in pregnancy: time to put the issue to rest. Obstet Gynecol 2013; 121:1158.
  13. Goldenberg RL, Cliver SP, Bronstein J, et al. Bed rest in pregnancy. Obstet Gynecol 1994; 84:131.
  14. Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999; 354:1229.
  15. Kovacevich GJ, Gaich SA, Lavin JP, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 182:1089.
  16. Maloni JA, Schneider BS. Inactivity: symptoms associated with gastrocnemius muscle disuse during pregnancy. AACN Clin Issues 2002; 13:248.
  17. Maloni JA, Kane JH, Suen LJ, Wang KK. Dysphoria among high-risk pregnant hospitalized women on bed rest: a longitudinal study. Nurs Res 2002; 51:92.
  18. Maloni JA, Alexander GR, Schluchter MD, et al. Antepartum bed rest: maternal weight change and infant birth weight. Biol Res Nurs 2004; 5:177.
  19. Maloni JA, Park S. Postpartum symptoms after antepartum bed rest. J Obstet Gynecol Neonatal Nurs 2005; 34:163.
  20. Promislow JH, Hertz-Picciotto I, Schramm M, et al. Bed rest and other determinants of bone loss during pregnancy. Am J Obstet Gynecol 2004; 191:1077.
  21. Agopian AJ, Lupo PJ, Canfield MA, et al. Swimming pool use and birth defect risk. Am J Obstet Gynecol 2013; 209:219.e1.
  22. Centers for Disase Control and Prevention. Question and answer: Zika virus infection and pregnancy. www.cdc.gov/zika/pregnancy/question-answers.html (Accessed on February 26, 2016).
  23. www.cdc.gov/mmwr/preview/mmwrhtml/mm54d812a1.htm (Accessed on August 29, 2006).
  24. Read JS, Klebanoff MA. Sexual intercourse during pregnancy and preterm delivery: effects of vaginal microorganisms. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1993; 168:514.
  25. Sayle AE, Savitz DA, Thorp JM Jr, et al. Sexual activity during late pregnancy and risk of preterm delivery. Obstet Gynecol 2001; 97:283.
  26. Daniell WE, Vaughan TL, Millies BA. Pregnancy outcomes among female flight attendants. Aviat Space Environ Med 1990; 61:840.
  27. Huch R, Baumann H, Fallenstein F, et al. Physiologic changes in pregnant women and their fetuses during jet air travel. Am J Obstet Gynecol 1986; 154:996.
  28. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 443: Air travel during pregnancy. Obstet Gynecol 2009; 114:954.
  29. Freeman M, Ghidini A, Spong CY, et al. Does air travel affect pregnancy outcome? Arch Gynecol Obstet 2004; 269:274.
  30. Magann EF, Chauhan SP, Dahlke JD, et al. Air travel and pregnancy outcomes: a review of pregnancy regulations and outcomes for passengers, flight attendants, and aviators. Obstet Gynecol Surv 2010; 65:396.
  31. Chibber R, Al-Sibai MH, Qahtani N. Adverse outcome of pregnancy following air travel: a myth or a concern? Aust N Z J Obstet Gynaecol 2006; 46:24.
  32. Artal R, Fortunato V, Welton A, et al. A comparison of cardiopulmonary adaptations to exercise in pregnancy at sea level and altitude. Am J Obstet Gynecol 1995; 172:1170.
  33. Barish RJ. In-flight radiation exposure during pregnancy. Obstet Gynecol 2004; 103:1326.
  34. National Council on Radiation Protection and Measurements. Limitation of exposure to ionizing radiation. NCRP Report 116. Bethesda (MD): NCRP; 1993.
  35. International Commission on Radiological Protection. 1990 Recommendations of the ICRP. ICRP Publication 60. In: Annals of the ICRP 21, Pergammon Press, New York 1991. p.42-46.
  36. Huch R. Physical activity at altitude in pregnancy. Semin Perinatol 1996; 20:303.
  37. Baumann H, Huch R. [Altitude exposure and staying at high altitude in pregnancy: effects on the mother and fetus]. Zentralbl Gynakol 1986; 108:889.
  38. Parer JT. Effects of hypoxia on the mother and fetus with emphasis on maternal air transport. Am J Obstet Gynecol 1982; 142:957.
  39. Kametas NA, McAuliffe F, Krampl E, et al. Maternal cardiac function during pregnancy at high altitude. BJOG 2004; 111:1051.
  40. Niermeyer S. The pregnant altitude visitor. Adv Exp Med Biol 1999; 474:65.
  41. Chua-Gocheco A, Bozzo P, Einarson A. Safety of hair products during pregnancy. October 2008. www.motherisk.org/prof/updatesDetail.jsp?content_id=890 (Accessed on January 05, 2010).
  42. Organization of Teratology Information Specialists. Hair treatments and pregnancy. www.OTISpregnancy.org (Accessed on January 05, 2010).
  43. www.cdc.gov/travel/bugs.htm (Accessed on March 15, 2007).
  44. Wilson DL, Barnes M, Ellett L, et al. Decreased sleep efficiency, increased wake after sleep onset and increased cortical arousals in late pregnancy. Aust N Z J Obstet Gynaecol 2011; 51:38.
  45. Hertz G, Fast A, Feinsilver SH, et al. Sleep in normal late pregnancy. Sleep 1992; 15:246.
  46. Okun ML, Kiewra K, Luther JF, et al. Sleep disturbances in depressed and nondepressed pregnant women. Depress Anxiety 2011; 28:676.
  47. www.sleepfoundation.org/article/sleep-topics/pregnancy-and-sleep (Accessed on October 06, 2011).
  48. Okun ML, Ebert R, Saini B. A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol 2015; 212:428.
  49. Heenan AP, Wolfe LA, Davies GA, McGrath MJ. Effects of human pregnancy on fluid regulation responses to short-term exercise. J Appl Physiol (1985) 2003; 95:2321.
  50. Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly 2001; 131:659.
  51. Loperamide. www.reprotox.org (Accessed on April 26, 2012).
  52. FRANCIS WJ. Disturbances of bladder function in relation to pregnancy. J Obstet Gynaecol Br Emp 1960; 67:353.
  53. Stanton SL, Kerr-Wilson R, Harris VG. The incidence of urological symptoms in normal pregnancy. Br J Obstet Gynaecol 1980; 87:897.
  54. van Brummen HJ, Bruinse HW, van der Bom JG, et al. How do the prevalences of urogenital symptoms change during pregnancy? Neurourol Urodyn 2006; 25:135.
  55. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005; 193:771.
  56. Palmsten K, Hernández-Díaz S, Chambers CD, et al. The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol 2015; 126:465.
  57. Smolina K, Hanley GE, Mintzes B, et al. Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study. PLoS One 2015; 10:e0128312.
  58. Frawley J, Adams J, Steel A, et al. Women's Use and Self-Prescription of Herbal Medicine during Pregnancy: An Examination of 1,835 Pregnant Women. Womens Health Issues 2015; 25:396.
  59. Dillon P, O'Brien KK, McDonnell R, et al. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth 2015; 15:67.
  60. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet 2011; 157C:175.
  61. www.Reprotox.org (Accessed on July 01, 2009).
  62. Feldkamp ML, Meyer RE, Krikov S, Botto LD. Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 2010; 115:109.
  63. Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 2014; 168:313.
  64. Thompson JM, Waldie KE, Wall CR, et al. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One 2014; 9:e108210.
  65. Stergiakouli E, Thapar A, Davey Smith G. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding. JAMA Pediatr 2016; 170:964.
  66. FDA Drug Safety Communication: FDA has reviewed possible risks of pain medicine use during pregnancy. US Food and Drug Administration, 2015.
  67. Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Electronic address: pubs@smfm.org. Prenatal acetaminophen use and outcomes in children. Am J Obstet Gynecol 2017; 216:B14.
  68. Kristensen DM, Hass U, Lesné L, et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011; 26:235.
  69. Snijder CA, Kortenkamp A, Steegers EA, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 2012; 27:1191.
  70. Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010; 21:779.
  71. Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician 2003; 67:2517.
  72. Geber WF, Schramm LC. Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol 1975; 123:705.
  73. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314.e1.
  74. Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981; 58:336.
  75. Yazdy MM, Mitchell AA, Tinker SC, et al. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol 2013; 122:838.
  76. Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ 2017; 189:E625.
  77. www.reprotox.org (Accessed on September 20, 2012).
  78. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009; 23:18.
  79. Bar-Oz B, Moretti ME, Boskovic R, et al. The safety of quinolones--a meta-analysis of pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2009; 143:75.
  80. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.
  81. Newman RD, Parise M, Nahlen B. Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 2001; 344:934; author reply 934.
  82. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961.
  83. Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009; 163:978.
  84. Källén BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003; 17:255.
  85. Nordeng H, Lupattelli A, Romøren M, Koren G. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 2013; 121:306.
  86. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol 2011; 117:1484.
  87. Forna F, McConnell M, Kitabire FN, et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006; 8:24.
  88. Klarskov P, Andersen JT, Jimenez-Solem E, et al. Short-acting sulfonamides near term and neonatal jaundice. Obstet Gynecol 2013; 122:105.
  89. ANDERSEN DH, BLANC WA, CROZIER DN, SILVERMAN WA. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18:614.
Topic Outline

GRAPHICS